The role of cytoreductive nephrectomy for renal cell carcinoma in the era of targeted therapy

被引：3
作者：
Chowdhury, Simon [1 ]
Harper, Peter G. [2 ]
Choueiri, Toni K.
机构：
[1] Guys Hosp, Dept Med Oncol, London SE1 9RT, England
[2] Guys & St Thomas Hosp, Natl Hlth Serv Trust, London SE1 9RT, England
来源：
NATURE CLINICAL PRACTICE ONCOLOGY | 2008年 / 5卷 / 12期
关键词：
D O I：
10.1038/ncponc1256
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：698 / 699
页数：2
相关论文
共 50 条
[41]   The evolving role of cytoreductive nephrectomy in metastatic renal cell carcinoma [J].
Graham, Jeffrey ;
Bhindi, Bimal ;
Heng, Daniel Y. C. .
CURRENT OPINION IN UROLOGY, 2019, 29 (05) :507-512
[42]   The role of cytoreductive nephrectomy in metastatic renal cell carcinoma. [J].
Alnimer, Yanal Mufeed ;
Qasrawi, Ayman ;
Katato, Khalil .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[43]   The current role of cytoreductive nephrectomy for metastatic renal cell carcinoma [J].
Umbreit, Eric C. ;
McIntosh, Andrew G. ;
Suk-Ouichai, Chalairat ;
Karam, Jose A. ;
Wood, Christopher G. .
INDIAN JOURNAL OF UROLOGY, 2021, 37 (01) :13-16
[44]   Current role of cytoreductive nephrectomy in metastatic renal cell carcinoma [J].
Van Praet, Charles ;
Slots, Charlotte ;
Vasdev, Nikhil ;
Roney, Sylvie ;
Fonteyne, Valerie ;
Andras, Lulia ;
Albersen, Maarten ;
De Meerleer, Gert ;
Bex, Axel ;
Decaestecker, Karel .
TURKISH JOURNAL OF UROLOGY, 2021, 47 :S79-S84
[45]   The role of cytoreductive nephrectomy in the management of metastatic renal cell carcinoma [J].
Wood, CG .
UROLOGIC CLINICS OF NORTH AMERICA, 2003, 30 (03) :581-+
[46]   Cytoreductive nephrectomy in the era of targeted- And immuno- therapy for metastatic renal cell carcinoma: An elusive issue? A systematic review of the literature [J].
Mazzaschi, Giulia ;
Quaini, Federico ;
Bersanelli, Melissa ;
Buti, Sebastiano .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 160
[47]   Role of cytoreductive nephrectomy (CRN) for metastatic renal cell carcinoma (mRCC) in the era of targeted therapy (TKI): experience from three hong kong tertiary centres [J].
Chan, K. W. ;
Tsu, H. L. ;
Ma, W. K. ;
Kan, C. F. ;
Leung, A. K. C. ;
Ip, C. H. ;
Kan, W. M. ;
Cheung, F. K. ;
Chan, W. H. ;
Au, W. H. ;
Yiu, M. K. .
BJU INTERNATIONAL, 2014, 113 :2-2
[48]   The Impact of Targeted Therapy on Management of Metastatic Renal Cell Carcinoma: Trends in Systemic Therapy and Cytoreductive Nephrectomy Utilization [J].
Psutka, Sarah P. ;
Kim, Simon P. ;
Gross, Cary P. ;
Van Houten, Holly ;
Thompson, R. Houston ;
Abouassaly, Robert ;
Weight, Christopher ;
Boorjian, Stephen A. ;
Leibovich, Bradley C. ;
Shah, Nilay D. .
UROLOGY, 2015, 85 (02) :442-450
[49]   Cytoreductive nephrectomy plus targeted therapy versus targeted therapy alone in metastatic renal cell carcinoma: a retrospective cohort study [J].
Choi, S. W. ;
Fok, C. Y. ;
Teoh, J. Y. ;
Hou, S. M. ;
Ng, C. F. .
BJU INTERNATIONAL, 2017, 119 :11-12
[50]   ROLE OF MOLECULAR MARKERS IN NEPHRECTOMY SPECIMEN AS PROGNOSTICATORS FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA IN THE ERA OF TARGETED THERAPY [J].
You, Dalsan ;
Cho, Yong Mee ;
Lee, Jae-Lyun ;
Song, Cheryn ;
Hong, Jun Hyuk ;
Kim, Choung-Soo ;
Ahn, Hanjong .
JOURNAL OF UROLOGY, 2012, 187 (04) :E181-E181
12345